EVE Health Group Limited (ASX:EVE)
Australia · Delayed Price · Currency is AUD 0.0210
-0.0010 (-4.76%)
Feb 11, 2026, 2:47 PM AEST
EVE Health Group Company Description
EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products.
The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erectile dysfunction.
It also offers Lactobacillus rhamnosus Beebiotic MAP01, a proprietary strain to support digestive health and vitality.
The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.
EVE Health Group Limited
| Country | Australia |
| Founded | 2003 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 3 |
| CEO | Gregory Fry |
Contact Details
Address: 245 Churchill Avenue Subiaco, Washington 6008 Australia | |
| Phone | 61 8 6465 5500 |
| Website | evehealthgroup.com.au |
Stock Details
| Ticker Symbol | EVE |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000EVE3 |
| SIC Code | 2090 |
Key Executives
| Name | Position |
|---|---|
| Benedict James Rohr | Chief Operating Officer |
| Dr. Stuart Gunzburg | CSO and Executive Director |
| Steven Luke Jackson BEc, C.P.A. | Chief Financial Officer and Company Secretary |
| Rebecca Bak | Marketing Manager |